Bill > S2304

This bill, the Drug-Price Transparency for Competition Act of 2021 or the DTC Act of 2021, would require direct-to-consumer advertisements for prescription drugs and biological products to include the wholesale acquisition cost (WAC), which is the list price set by the manufacturer, for a 30-day supply or typical course of treatment. The goal is to provide consumers with more pricing information to make informed decisions about their healthcare. The bill also allows for additional qualitative or quantitative information about the price and possible differences based on insurance coverage. The Secretary of Health and Human Services would have the authority to enforce the requirement and impose civil money penalties for violations.